With reference to the earlier letter dated October 26, 2015, informing that a Meeting of the Board of Directors of the Company will be held on November 06, 2015 to consider, the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2015. Further Aurobindo Pharma has now informed that at the Board Meeting to be held on November 06, 2015, the Board will also consider the proposal of payment of Second Interim Dividend for the year 2015-16.
The above information is a part of company’s filings submitted to BSE.
